TrialMovement disorders : official journal of the Movement Disorder Society2017

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).

Wolfgang Oertel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.